Leadership

Poseida’s leaders have deep experience and proven track records at some of the world’s leading pharma and biotech firms.

Management

Eric M. Ostertag, M.D., Ph.D.

Chief Executive Officer

Mark J. Gergen

President & Chief Business Officer

Kristin Martin

Chief People and Administration Officer

Johanna Mylet, C.P.A.

Chief Financial Officer

Matthew A. Spear, M.D.

Chief Medical Officer

Kerry Ingalls

Chief Operating Officer

Devon J. Shedlock, Ph.D.

Chief Scientific Officer, Cell Therapies

Harry J. Leonhardt, Esq.

General Counsel, Chief Compliance Officer & Corporate Secretary

Lisa Portale

Senior Vice President, Regulatory Affairs

Marcy Graham

Vice President, Corporate Affairs

Karen Basbaum

Vice President, Business Development

Jeffrey W. Winkelman, Ph.D., J.D.

Vice President, Intellectual Property

Board of Directors

Eric M. Ostertag, M.D., Ph.D.

Mark J. Gergen

Cynthia Collins

Luke Corning

David Hirsch, M.D., Ph.D.

Marcea Bland Lloyd, J.D.

John Schmid

Scientific Advisory Board

Carl June, M.D.

Luca Gattinoni, M.D.

Christine Brown, Ph.D.

Jan Joseph Melenhorst, Ph.D.

MENU